Article info
Original Articles
Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma
- Address correspondence and reprint request to: Paivi Kannisto, MD, PhD, Department of Obstetrics and Gynecology, University Hospital of Lund, 22185 Lund, Sweden. Email: paivi.kannisto{at}med.lu.se
Citation
Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma
Publication history
- First published July 1, 2006.
Online issue publication
July 01, 2006
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2006, IGCS